Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Trends Biotechnol. 2021 Sep 20;40(4):432–447. doi: 10.1016/j.tibtech.2021.08.007

Figure 2.

Figure 2.

Bioengineering next-generation cancer models through rational combination of advanced biofabrication technologies and microfluidic chips with programmed designs as a strategy to give rise to highly physiomimetic 3D-bioprinted organ-on-a-chip platforms recapitulating fluid dynamics and TME heterogeneity, ultimately providing unique breakthroughs in in vitro cancer modelling.